Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Urmi Sengupta

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Progress in Neurobiology|April 21, 2022
Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseasesUrmi Sengupta, Rakez Kayed
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2018
Amyloid oligomer interactions and polymorphisms: disease-relevant distinct assembly of α-synuclein and tauUrmi Sengupta, Rakez Kayed
Methods in Molecular Biology (Clifton, N.J.)|March 21, 2024
Tau Oligomers as Pathogenic Seeds: Preparation, Characterization, and Propagation In Vitro and In VivoUrmi Sengupta, Rakez Kayed
NPJ Vaccines|March 7, 2018
Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathiesAlice Bittar, Urmi Sengupta, Rakez Kayed
Ebiomedicine|May 24, 2016
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and ImmunotherapyUrmi Sengupta, Ashley N Nilson, Rakez Kayed
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2018
Preparation and Characterization of Tau Oligomer StrainsUrmi Sengupta, Mariana Carretero-Murillo, Rakez Kayed
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2016
Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In VivoJulia E Gerson, Urmi Sengupta, Rakez Kayed
Plos One|December 10, 2009
Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complicationsUrmi Sengupta, Sanchaita Ukil, Nevenka Dimitrova, et al.
Brain Pathology (Zurich, Switzerland)|September 2, 2022
Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodiesMauro Montalbano, Lajja Majmundar, Urmi Sengupta, et al.
Journal of Alzheimer'S Disease : JAD|April 29, 2017
Tau Oligomers in Sera of Patients with Alzheimer's Disease and Aged ControlsMichala Kolarova, Urmi Sengupta, Ales Bartos, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Progress in Neurobiology|April 21, 2022
Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseasesUrmi Sengupta, Rakez Kayed
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2018
Amyloid oligomer interactions and polymorphisms: disease-relevant distinct assembly of α-synuclein and tauUrmi Sengupta, Rakez Kayed
Methods in Molecular Biology (Clifton, N.J.)|March 21, 2024
Tau Oligomers as Pathogenic Seeds: Preparation, Characterization, and Propagation In Vitro and In VivoUrmi Sengupta, Rakez Kayed
NPJ Vaccines|March 7, 2018
Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathiesAlice Bittar, Urmi Sengupta, Rakez Kayed
Ebiomedicine|May 24, 2016
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and ImmunotherapyUrmi Sengupta, Ashley N Nilson, Rakez Kayed
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2018
Preparation and Characterization of Tau Oligomer StrainsUrmi Sengupta, Mariana Carretero-Murillo, Rakez Kayed
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2016
Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In VivoJulia E Gerson, Urmi Sengupta, Rakez Kayed
Plos One|December 10, 2009
Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complicationsUrmi Sengupta, Sanchaita Ukil, Nevenka Dimitrova, et al.
Brain Pathology (Zurich, Switzerland)|September 2, 2022
Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodiesMauro Montalbano, Lajja Majmundar, Urmi Sengupta, et al.
Journal of Alzheimer'S Disease : JAD|April 29, 2017
Tau Oligomers in Sera of Patients with Alzheimer's Disease and Aged ControlsMichala Kolarova, Urmi Sengupta, Ales Bartos, et al.
Pageof 6